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In the adult central nervous system, lesioned axons fail to regenerate. The failure of
axon regeneration is attributable to axonal growth inhibitors encountered by
injured axons, including semaphorins. By using a combinatorial screening
strategy, Montolio et al. have identified a stable peptoid (SICHI) that specifically
blocks semaphorin 3A (Sema 3A) biological functions, including chemorepulsion,
in both the developing and the adult brain. Moreover, SICHI enhanced the regen-
eration of lesioned axons in slice cultures. Given the involvement of Sema 3A in
CNS regeneration and other human pathologies, the authors suggest that SICHI
offers great potential for therapeutic approaches for diseases related to sema-
phorin function and axonal regeneration.
LXXLL-Peptides Perturb ERa Localization
PAGE 702
Synthetic peptide probes featuring specific estrogen receptor a (ERa) interaction
motifs and visualization and localization tags, developed here by Carraz et al.,
allow probing the surface of the full-length ERa in cells. The LXXLL-peptide probes disrupt ERa–coactivator interactions,
which can be monitored by confocal scanning microscopy. A successful recognition of the molecular surface of the ERa
by the peptide probes results in the displacement of the ERa from the DNA and coactivator and leads to the ERa translocation
into the nucleoli. The method enables quantification of the ERa nucleoli recruitment and can be used to assess the affinity of
peptide sequences for ERa in the physiological context of a cell.
Morphological Screening for MOA and Off-Target Effects
PAGE 712
Interaction of drugs with unintended targets is a major source of concern in drug discovery and development and one of the
reasons for high attrition rates. Now, Abassi et al. describe an approach that utilizes microelectronics to monitor both the
short-term and long-term kinetics of cellular responses to drugs and experimental compounds. The authors demonstrate
the utility of this approach by highlighting several examples in which they have identified either newmechanisms or additional
mechanisms for existing drugs and experimental compounds.
OBOC Comes to Focus
PAGE 724
The need to resynthesize primary hit compounds before determining their affin-
ities in homogenous solution is an essential bottleneck in on-bead screening of
large one-bead, one-compound libraries. Hintersteiner et al. use a single-bead
labeling and analysis method for linking on-bead screening by automated
confocal nanoscanning and bead picking, (CONA), with quantitative affinity
measurements in solution by single molecule spectroscopy, compound quality
control by HPLC, and structure determination byMS. Thismethod is embedded
into an integrated screening process spanning from design to single-cell
validation of small molecular binders and inhibitors. (Figure adapted from
Hintersteiner et al.)
Enzymes in Cyclooctatin Biosynthesis
PAGE 736
Cyclooctatin, a diterpene characterized by a 5-8-5 fused ring system, is a potent inhibitor of lysophospholipase. Kim et al.
report the cloning and characterization of a complete cyclooctatin biosynthetic gene cluster consisting of four cotB genes
from Streptomyces melanosporofaciens MI614-43F2 and heterologous production of cyclooctatin in S. albus. Incubation
of the recombinant CotB2 enzyme with geranylgeranyl diphosphate resulted in the formation of an unprecedented tricyclic
diterpene alcohol. The present study establishes the complete biosynthetic pathway of cyclooctatin and provides insights
into both the stereo-specific diterpene cyclization mechanism of the geranylgeranyl diphosphate cyclase and the molecular
bases for the stereo- and regiospecific hydroxylation.Chemistry & Biology 16, July 31, 2009 ª2009 Elsevier Ltd All rights reserved ix
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Endocannabinoids are signaling lipids that regulate a broad spectrum of mammalian physiological and behavioral processes.
Monoacylglycerol lipase (MAGL) is a principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG).
Here, Long et al. use the selective inhibitor JZL184 to globally assess the contribution that MAGLmakes to the metabolism of
2-AG. These studies identify organs, such as brain, whereMAGL exerts profound control over 2-AG signaling and, conversely,
tissues where other enzymes might contribute to 2-AG and monoglyceride metabolism. This knowledge should guide the
advancement of MAGL inhibitors as potential pharmaceutical agents for human disorders that would benefit from heightened
endocannabinoid signaling.
pHLIP Brings Molecules into Cells
PAGE 754
A broad range of cell-impermeable molecules is excluded from discovery efforts
because they cannot traverse membranes on their own. In their study, The´venin
et al. explore the properties of the peptide pHLIP, which can target tumors based
on their acidity, as a delivery system by defining some of the properties of mole-
cules that can be translocated into cells. The authors show that pHLIP can effi-
ciently deliver membrane-impermeable peptides into cancer cells and that the
translocation is pH dependent and mediated by transmembrane helix formation.
Thus, pHLIP might have the potential to expand therapeutic options for acidic
tissues such as tumors and sites of inflammation and to mitigate the side effects
associated with conventional chemotherapy. (Figure provided by The´venin et al.)
Acylhydrazone-Based Cleavable Linkers
PAGE 763
Proteomic searches using affinity-based chromatography [e.g., biotin-(strept)avidin] have been severely hampered by low-
protein recovery yields, protein destruction and denaturation, and the release of background proteins from the support. These
limitations have confounded protein identification. Park et al. now describe an acylhydrazone-based cleavable linker that
permits the efficient isolation of proteins with a traceable tag (i.e., isotopic, fluorescent) allowing detection and identification
under mild conditions. Protein release proceeded with significantly reduced levels of background proteins. The use of acyl-
hydrazone linkers is expected to be generalized allowing for the selective release of tagged molecules from noncovalent and
covalently tagged supports.
Dumbbell-Shaped Cell Adhesion and Growth Promoter
PAGE 773
During an image-based phenotype screening of a chemical library, Yamazoe
et al. made a discovery of a small molecule that boosts the adhesion and
growth of human cells. Follow-up chemical and cell biological experiments
suggested that the diaryldispirotripiperazine derivative (adhesamine) targets
selective cell-surface glycosaminoglycans, especially heparan sulfate, and
increases cell adhesion and growth. Adhesamine induces apparently normal
cell adhesion accompanied with organized actin structures and activation of
FAK and ERK. Additionally, adhesamine was shown to enable the adhesion
of floating lymphocytes to cell culture plates, thus facilitating the lympho-
cytes’ microinjection process. Therefore, adhesamine may find its use as
a cell-attaching reagent for cell engineering and basic cell biology.
IL-6 Inhibitor by Fusion ofReceptor Fragments
PAGE 783
Inhibitors of proinflammatory cytokines are effective drugs in the treatment of chronic inflammatory diseases. Here, Wiesinger
et al. present the development of an inhibitor of murine IL-6, mIL-6-RFP, which is based on the fusion of the IL-6 receptor
proteins IL-6Ra and gp130. The concept of inline fusion of receptor fragments has the great advantage that the inhibitor is
encoded by a single gene, as compared to antibodies or cytokine traps, where two subunits have to be expressed in parallel.
This strategy offers numerous possibilities for specific cytokine inhibition in gene delivery approaches based on viral vectors,
transgenic animals and finally gene therapy.x Chemistry & Biology 16, July 31, 2009 ª2009 Elsevier Ltd All rights reserved
